List of Vazalore drug patents

Vazalore is owned by Plx Pharma.

Vazalore contains Aspirin.

Vazalore has a total of 4 drug patents out of which 2 drug patents have expired.

Expired drug patents of Vazalore are:

  • US9101637
  • US8865187

Vazalore was authorised for market use on 14 January, 2013.

Vazalore is available in capsule;oral dosage forms.

Vazalore can be used as treatment/prevention of cardiovascular disease; temporary relief of minor aches and pains; temporary reduction of fever, treatment/prevention of cardiovascular disease; temporary reduction of fever; temporary relief of minor aches and pains.

The generics of Vazalore are possible to be released after 29 September, 2032.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9101637 PLX PHARMA Methods of treating inflammation with compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity
Mar, 2022

(10 months ago)

US8865187 PLX PHARMA Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity
Mar, 2022

(10 months ago)

US9226892 PLX PHARMA pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
Sep, 2032

(9 years from now)

US9216150 PLX PHARMA pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
Sep, 2032

(9 years from now)

Drugs and Companies using ASPIRIN ingredient

Market Authorisation Date: 14 January, 2013

Treatment: Treatment/prevention of cardiovascular disease; Temporary reduction of fever; Temporary relief of minor aches and pains

Dosage: CAPSULE;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in